Impact of variable fee schedule reimbursement (VFSR) on anti-emetic utilization and quality of care.
Early economic benefits of gene expression profiling using a 21-gene panel among patients with early stage, lymph node negative, hormone receptor positive, her2-neu oncogene negative breast cancer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results